In this paper, we investigated Cdx2 and claudin-2 expression in pathological paraffin tissues of sinus ventriculi from gastroscopic biopsy to determine the correlation between the expressions of these 2 genes during gastric carcinogenesis by immunochemical ABC technique. Altogether, we analyzed 108 chronic superficial gastritis, 55 chronic atrophic gastritis, 109 intestinal-type metaplasia, 93 dysplasia and 52 gastric intestinal-type adenocarcinoma samples. Our results indicated that the percentage of Cdx2-positive cases was 0% (0/108) for chronic superficial gastritis, 0% (0/55) for chronic atrophic gastritis, 90.83% (99/109) for intestinal-type metaplasia, 51.61% (48/93) for dysplasia and 61.54% (32/52) for gastric intestinal-type adenocarcinoma, primarily expressed in the cell nucleus and partly in the cytoplasm (p < 0.05); interestingly, the percentage for the intestine-type metaplasia was markedly high. The percentage of claudin-2-positive cases was 0% (0/108) for chronic superficial gastritis, 0% (0/55) for chronic atrophic gastritis, 0% (0/109) for intestinal-type metaplasia, 35.48% (33/93) for dysplasia and 71.15% (37/52) for gastric intestinal-type adenocarcinoma, primarily in the cell membrane and gradually increased in the multistage process of gastric carcinogenesis (p < 0.05). Significant correlations were found between claudin-2 and Cdx2 protein expression in dysplasia and intestine-type adenocarcinoma (r = 0.112, p < 0.05). Thus, there may be a correlation between the expression of claudin-2 and Cdx2 in stages of dysplasia and cancer.

Keywords:
Cdx2, Claudin-2, Immunohistochemistry, Multistage tissue, Carcinogenesis
1.
Sasaki H, Matsui C, Furuse K: Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc Natl Acad Sci USA 2003;100:3971–3976.
2.
Tsukita S, Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000;149:13–16.
3.
Furuse M, Sasaki H, Fujimoto K: A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998;143:391–401.
4.
Furuse M, Sasaki H, Tsukita S: Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999;147:891–903.
5.
Simon DB, Lu Y, Choate KA: Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999;285:103–106.
6.
Tsukita S, Furuse M, Itoh M: Multifunctional strands in TJ. Nat Rev Mol Cell Biol 2001;2:285–293.
7.
Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, Fromm M: Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002;115:4969–4976.
8.
Sakaguchi T, Gu X, Golden HM: Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1α. J Biol Chem 2002;277:21361–21370.
9.
Charite J, de Graaff W, Consten D: Transducing positional information to the Hox genes: critical interaction of cdx gene products with position-sensitive regulatory elements. Development 1998;125:4349–4358.
10.
Duprey P, Chowdhury K, Dressler GR: A mouse gene homologous to the Drosophila gene caudal is expressed in epithelial cells from the embryonic intestine. Genes Dev 1988;2:1647–1654.
11.
Suh E, Chen L, Taylor J: A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 1994;14:7340–7351.
12.
Yuasa Y: Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592–600.
13.
Rao JN, Li J, Li L: Differentiated intestinal epithelial cells exhibit increased migration through polyamines and myosin II. Am J Physiol 1999;277:1149–1158.
14.
Faller G, Kirchner T: Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 2005;446:1–9.
15.
Bai YQ, Yamamoto H, Akiyama Y: Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 2002;176:47–55.
16.
Dixon MF, Genta RM, Yardley JH: Classification and grading of gastritis: the updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–1181.
17.
Rugge M, Correa P, Dixon MF: Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000;24:167–176.
18.
Jass JR: Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 1980;33:801–810.
19.
Craanen ME, Blok P, Dekker W: Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci 1991;36:1529–1536.
20.
Laurén P: The two histological main types of gastric carcinoma, diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31–49.
21.
Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005;46:551–560.
22.
Shibuya K, Mathers CD, Boschi-Pinto C: Global and regional estimates of cancer mortality and incidence by site. 2. Results for the global burden of disease. BMC Cancer 2002;2:37.
23.
Correa P: Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 1996;5:477–481.
24.
Mutoh H, Hakamata Y, Sato K: Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 2002;294:470–479.
25.
Mallo GV, Rechreche H, Frigerio JM: Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997;74:35–44.
26.
Moskaluk CA, Zhang H, Powell SM: Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 2003;16:913–919.
27.
Chawengsaksophak K, James R, Hammond VE: Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997;386:84–87.
28.
Ee HC, Erler T, Bhathal PS: Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995;147:586–592.
29.
Mallo GV, Soubeyran P, Lissitzky JC: Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 1998;273:14030–14036.
30.
Suh E, Traber PG: An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 1996;16:619–625.
31.
Morita K, Furuse M, Fujimoto K: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999;96:511–516.
32.
Kiuchi-Saishin Y, Gotoh S, Furuse M: Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002;13:875–886.
33.
Rendon-Huerta E, Valenzano MC, Mullin JM: Comparison of three integral tight junction barrier proteins in Barrett’s epithelium versus normal esophageal epithelium. Am J Gastroenterol 2003;98:1901–1903.
34.
Miyoshi J, Takai Y: Molecular perspective on tight-junction assembly and epithelial polarity. Adv Drug Deliv Rev 2005;57:815–855.
35.
Rahner C, Mitic LL, Anderson JM: Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001;120:411–422.
36.
Cereghini S: Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 1996;10:267–282.
37.
Wasylyk C, Wasylyk B, Heidecker G: Expression of raf oncogenes activates the PEA1 transcription factor motif. Mol Cell Biol 1989;9:2247–2250.
38.
Gilmore TD: NF-kappa B, KBF1, dorsal, and related matters. Cell 1990;62:841–843.
39.
Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 1992;80:575–581.
40.
Escaffit F, Boudreau F, Beaulieu JF: Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 2005;203:15–26.
41.
Yamamoto T, Kojima T, Murata M: IL-1β regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp Cell Res 2004;299:427–441.
42.
Naumann M, Crabtree JE: Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol 2004;12:29–36.
43.
Sonoda N, Furuse M, Sasaki H: Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999;147:195–204.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.